Jason Cassorla Stock Analyst Profile - Guggenheim Research Coverage - Stocknear

Jason Cassorla

Stock Analyst at Guggenheim

(3.86)
# 2158
Out of 5,506 analysts
68
Total ratings
Success rate
Average return

20 Stocks

Name Action PT Current % Upside Ratings Updated
HUM Humana
Reiterates: Buy
n/a
n/a n/a 2 Oct 3, 2025
ACHC Acadia Healthcare Co
Maintains: Buy
36 29
27.14 6.85% 2 Aug 7, 2025
CI Cigna Group
Maintains: Buy
388 350
310.96 12.55% 5 Aug 4, 2025
THC Tenet Healthcare
Maintains: Strong Buy
180 188
202.96 -7.37% 9 Jul 23, 2025
ELV Elevance Health
Maintains: Buy
447 360
350.49 2.71% 3 Jul 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
16 18
14.02 28.39% 2 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 2 Apr 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
208
207.14 0.42% 6 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 6 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 6 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
45
13.7 228.47% 3 Sep 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
38 36
21.15 70.21% 6 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 13
n/a n/a 4 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
1 2
2.59 -42.08% 3 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
400 80
n/a n/a 3 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
16 18
8.13 121.4% 2 Feb 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
5 8
5.01 59.68% 1 Nov 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
180 96
n/a n/a 1 Nov 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
70 60
n/a n/a 1 Nov 8, 2022